Trial Profile
Simeprevir, sofosbuvir and ribavirin to treat genotype 1 patients with chronic hepatitis and psychiatric disorders for whom interferon therapy is contraindicated.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 20 May 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary) ; Vitamin D
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms INSPIRE-C
- 20 May 2015 New trial record